DESTINY-PanTumor02 study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analyses of HER2 expression and gene amplification in tissue and plasma Meeting Abstract
| Authors: | Makker, V.; Lee, J. Y.; Oh, D. Y.; Oaknin, A.; Puvvada, S. D.; Cecchi, F.; McEwen, R.; Michelini, F.; Meric-Bernstam, F. |
| Abstract Title: | DESTINY-PanTumor02 study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analyses of HER2 expression and gene amplification in tissue and plasma |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S239 |
| End Page: | S240 |
| Language: | English |
| ACCESSION: | WOS:001087480200144 |
| DOI: | 10.1016/j.annonc.2023.09.2872 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 148P -- Source: Wos |
